Urinary excretion of aminohydroxypropylidene bisphosphonate in cancer patients after single intravenous infusions

End-of-dose akinesia after a single intr

End-of-dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: A pharmacokinetic/pharmacodynamic, randomized, double-blind study

✍ Nicolas Simon; Joëlle Micallef; Jean-Charles Reynier; Monique Lesourd; Tatiana W 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 130 KB 👁 1 views

## Abstract This randomized, double‐blind trial was designed to define the possible relationship between piribedil plasma concentrations and the decrease of the Unified Parkinson's Disease Rating Scale (UPDRS) motor score or the switch from __off__ to __on__ state after single intravenous infusion.